B cell depletion and regeneration (CD19) after rituximab therapy.... | Download Scientific Diagram
B cell repopulation and time of B cell depletion after rituximab. B... | Download Scientific Diagram
Monitoring B-cell repopulation after depletion therapy in neurologic patients | Neurology Neuroimmunology & Neuroinflammation
JCM | Free Full-Text | Rituximab Therapy for Adults with Nephrotic Syndromes: Standard Schedules or B Cell-Targeted Therapy? | HTML
B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome | American Society of Nephrology
Rituximab for the treatment of multiple sclerosis: a review | SpringerLink
Frontiers | B Cell Therapy in Systemic Lupus Erythematosus: From Rationale to Clinical Practice
Frontiers | Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis
Rituximab in the treatment of multiple sclerosis in the Hospital District of Southwest Finland - Multiple Sclerosis and Related Disorders
B cell depletion with ublituximab reshapes the T cell profile in multiple sclerosis patients - ScienceDirect
Prolonged B-cell depletion after rituximab in AQP4-IgG-positive neuromyelitis optica spectrum disorder - ScienceDirect
Consequences of B-cell-depleting therapy: hypogammaglobulinemia and impaired B-cell reconstitution | Immunotherapy
International Clinical Cytometry Society
Immunotherapy and Immune Monitoring B Cell Monitoring During Anti-B Treatment in Autoimmune Diseases The Changing Scenario of Im
Titrating Rituximab to Circulating B Cells to Optimize Lymphocytolytic Therapy in Idiopathic Membranous Nephropathy | American Society of Nephrology
Depletion of normal B cells with rituximab as an adjunct to IL-2 therapy for renal cell carcinoma and melanoma - Annals of Oncology
Immunotherapy and Immune Monitoring B Cell Monitoring During Anti-B Treatment in Autoimmune Diseases The Changing Scenario of Im
Effect of different initial rituximab regimens on B cell depletion in children with autoimmune neurological diseases - Multiple Sclerosis and Related Disorders
Clinical Response and Pattern of B cell Suppression with Single Low Dose Rituximab in Nephrology | American Society of Nephrology
Predicting and managing primary and secondary non-response to rituximab using B-cell biomarkers in systemic lupus erythematosus | Annals of the Rheumatic Diseases
Monitoring B-cell repopulation after depletion therapy in neurologic patients | Neurology Neuroimmunology & Neuroinflammation
Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease | PNAS
Therapeutic target of memory B cells depletion helps to tailor administration frequency of rituximab in myasthenia gravis - ScienceDirect
